New study reveals around a quarter of dementia patients are prescribed risky drugs despite safety warnings

Roughly 25 percent of dementia patients were prescribed at least one ‘potentially inappropriate’ drug between 2013 and 2021 ...
The Mirror US on MSN

New study finds dementia patients have been prescribed drugs that can cause delirium

Researchers are sounding the alarm on dangerous stimulant medications commonly prescribed to dementia patients in the U.S.
MarketWatch

Central Nervous System (CNS) Stimulant Drugs Market size is set to grow by USD 6.48 billion from 2023-2027, Rise in incidence of CNS disorders boost the market, Technavio

NEW YORK, July 12, 2024 /PRNewswire/ -- The global central nervous system (CNS) stimulant drugs market size is estimated to grow by USD 6.48 billion from 2023-2027, according to Technavio. The market ...
Medical Xpress

Central Nervous System Stimulants

Annual prescriptions for drugs to treat attention-deficit/hyperactivity disorder (ADHD) increased 157% in Ontario from 2015 to 2023, according to a new study from ...
Healio

Almost 50% of adults taking schedule II stimulants also use other psychiatric drugs

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. None of the combinations of stimulants and other ...
MedPage Today

FDA Updates Warnings on All Stimulants for ADHD, Other Conditions

The FDA is updating warnings for stimulants prescribed for attention-deficit/hyperactivity disorder (ADHD) and other conditions, citing concerns about nonmedical use ...
Business Wire

FDA Approves Supplemental New Drug Application for Adhansia XR® (methylphenidate HCl) Extended-Release Capsules CII

STAMFORD, Conn.--(BUSINESS WIRE)--Adlon Therapeutics L.P., a subsidiary of Purdue Pharma L.P., announced that the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application ...